4
Changes in Ownership
Sonoma Pharmaceuticals, Inc. Filed Acc 0001683168-18-002012
Options or other derivatives
- Chief Financial Officer acquired 67,733 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Miller Robert E Chief Financial Officer | 2018-07-20 | Grant or award · Stock option (right to buy) | +67,733 | 209,071 | D | ||
Loading xslF345X03/ownership.xml…